13F Filings History of venBio Partners L.P.

Latest 13F report
Q4 2018 - 14 Feb 2019
Value $
$38,077,000
Signature - Title
Robert Adelman - Member of the General Partner
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by venBio Partners L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. venBio Partners L.P. reported 3 stock holdings with total value $38,077,000 as of Q4 2018. Top holdings included Apellis Pharmaceuticals, Inc, VRNA, and MNLO.

Notify me when venBio Partners L.P. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2018 3 $38,077,000 $0 $0 $0 Apellis Pharmaceuticals, Inc, VRNA, MNLO 13F-HR 14 Feb 2019, 13:35
Q3 2018 3 $57,170,000 $0 -$27,369,923 -$27,369,923 Apellis Pharmaceuticals, Inc, MNLO, VRNA 13F-HR 14 Nov 2018, 09:55
Q2 2018 4 $96,922,000 $0 -$13,027,732 -$13,027,732 Apellis Pharmaceuticals, Inc, VRNA, MNLO, Nabriva Therapeutics PLC 13F-HR 14 Aug 2018, 15:39
Q1 2018 4 $162,246,000 +$54,925,000 $0 +$54,925,000 Apellis Pharmaceuticals, Inc, MNLO, VRNA, Nabriva Therapeutics PLC 13F-HR 25 Apr 2018, 14:09
Q4 2017 3 $100,757,000 $0 $0 $0 Apellis Pharmaceuticals, Inc, Nabriva Therapeutics PLC, VRNA 13F-HR 25 Apr 2018, 13:42